Ultrasonographic railway sign in tunnels as a new independent risk factor of adalimumab failure in hidradenitis suppurativa - 24/02/23
Doi : 10.1016/j.jaad.2022.08.064
Piotr K. Krajewski, MD a, b, Abdulhadi Jfri, MD, MSc c, Gemma Ochando-Ibernón, MD c, Antonio Martorell, MD, PhD c, ⁎ 
a Department of Dermatology, Venereology, and Allergology, Wroclaw Medical University, Wroclaw, Poland
b Department of Dermatology, Hospital de Manises, Valencia, Spain
c Harvard Medical School, Boston, MA
∗Correspondence and reprint requests to: Antonio Martorell, MD, PhD, Department of Dermatology, Hospital de Manises, Avenida Generalitat, 50 Manises, Valencia 46940, SpainDepartment of DermatologyHospital de ManisesAvenida Generalitat50 ManisesValencia46940Spain
Key words : Adalimumab, biologics, failure, fistulas, hidradenitis suppurativa, imaging, tunnel, ultrasonography
| Funding sources: None. |
|
| IRB approval status: Not applicable. |
© 2022
Publié par Elsevier Masson SAS.
Vol 88 - N° 3
P. 732-734 - mars 2023 Retour au numéro
Article précédent
- Measurement of psoriasis-affected area with artificial neural network
- Woo Hyup Lee, Sungmin Lee, Jiho Kim, Ju Hee Han, Yeong Ho Kim, Junhwi Kim, Ji Hyun Lee, Chul Hwan Bang
- E-visits for isotretinoin management have no effect on interruptions in care
- Kelsey Gradwohl, Neil Vaishampayan, Milad Eshaq, Yolanda Helfrich
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?